Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Thymogen structure

Thymogen

Immune
Phase 2 Research
45%
Low Risk
1/5

Warnings

Russian origin - limited Western data
Monitor immune function

Contraindications

PregnancyBreastfeeding

Drug Interactions

Immunosuppressants

Possible Side Effects

Nasal IrritationMild Headache

Legal & Regulatory

FDA Status Not FDA Approved
WADA Status Not Prohibited
Approved In Russia, CIS
Prescription Required

Pregnancy

Category C - Caution